NASDAQ:BCYC
Bicycle Therapeutics plc
- Stock
locale
United Kingdommarket
STOCKSindustry
Biotechnologywebsite
www.bicycletherapeutics.comipo date
May 23, 2019
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The company's oncology product candidat...Show More
Earnings
Earnings Release in 5 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus